Inhaled corticosteroids and decline of lung function in community residents with asthma

P. Lange, H. Scharling, C. S. Ulrik, J. Vestbo

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Background: Inhaled corticosteroids (ICS) constitute the cornerstone of treatment for asthma. Many studies have reported beneficial short term effects of these drugs, but there are few data on the long term effects of ICS on the decline in forced expiratory volume in 1 second (FEV1). This study was undertaken to determine whether adults with asthma treated with ICS have a less pronounced decline in FEV1 than those not treated with ICS. Methods: Two hundred and thirty four asthmatic individuals from a longitudinal epidemiological study of the general population of Copenhagen, Denmark were divided into two groups; 44 were treated with ICS and 190 were not treated with ICS. The annual decline in FEV1 was measured over a 10 year follow up period. Results: The decline in FEV1 in the 44 patients receiving ICS was 25 ml/year compared with 51 ml/year in the 190 patients not receiving this treatment (p
    Original languageEnglish
    Pages (from-to)100-104
    Number of pages4
    JournalThorax
    Volume61
    Issue number2
    DOIs
    Publication statusPublished - Feb 2006

    Keywords

    • Administration, Inhalation
    • administration & dosage: Adrenal Cortex Hormones
    • drug therapy: Asthma
    • Disease Progression
    • Female
    • drug effects: Forced Expiratory Volume
    • Humans
    • Male
    • Middle Aged
    • Research Support, Non-U.S. Gov't
    • physiology: Vital Capacity

    Fingerprint

    Dive into the research topics of 'Inhaled corticosteroids and decline of lung function in community residents with asthma'. Together they form a unique fingerprint.

    Cite this